Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14297644 | 0.93 | — | — | |
| SCHEMBL15491271 | 0.93 | — | — | |
| SCHEMBL14146867 | 0.83 | — | — | |
| SCHEMBL10092703 | 0.82 | — | — | |
| SCHEMBL17729865 | 0.79 | — | — | |
| SCHEMBL18791640 | 0.77 | — | — | |
| SCHEMBL23416780 | 0.77 | — | — | |
| SCHEMBL20033681 | 0.77 | — | — | |
| SCHEMBL20436104 | 0.74 | — | — | |
| SCHEMBL4654337 | 0.73 | ALDH1A1 (0.36) | ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5275669-A | Degreasing glass, metal, plastic and fiber surfaces | ALLIEDSIGNAL INC. (US) | 1994-01-04 | — | — | US | claimed |
| US-20240217930-A1 | SARS-COV-2 MPRO INHIBITOR COMPOUNDS | HEPTARES THERAPEUTICS LIMITED (GB) | 2024-07-04 | — | — | US | disclosed |
| US-11860536-B2 | Three-dimensional crosslinker composition and method of manufacturing electronic devices using the same | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2024-01-02 | — | — | US | disclosed |
| US-11787794-B2 | Aminothiazole compounds and methods using same | TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2023-10-17 | — | — | US | disclosed |
| EP-3743430-B1 | AMINOPYRROLOTRIAZINES AS KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20230234929-A1 | RAS INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT | 2023-07-27 | — | — | US | disclosed |
| US-20230233569-A1 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT | 2023-07-27 | — | — | US | disclosed |
| US-11700765-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-11 | — | — | US | disclosed |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230135758-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | UNIV CALIFORNIA (US) | 2023-05-04 | — | — | US | disclosed |
| US-20090226382-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. (US) | 2009-09-10 | — | — | US | disclosed |
| US-20090191141-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. (US) | 2009-07-30 | — | — | US | disclosed |
| US-20090104136-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | LIVING PROOF, INC. | 2009-04-23 | — | — | US | disclosed |
| WO-2009003999-A2 | CHEMICAL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-01-08 | — | — | WO | disclosed |
| US-20070161685-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-07-12 | — | — | US | disclosed |
| US-20070161685-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-07-12 | — | — | US | disclosed |
| US-20070135631-A1 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2007-06-14 | — | — | US | disclosed |
| WO-2007062314-A2 | HETEROCYCLIC CETP INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-1193309-B1 | Solvent blend for use in high purity precursor removal | AIR PROD & CHEM (US) | 2004-11-03 | — | — | EP | disclosed |
| EP-1193309-A1 | Solvent blend for use in high purity precursor removal | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2002-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217930-A1 | SARS-COV-2 MPRO INHIBITOR COMPOUNDS | ACE2, SARS1, ACE | ALDH1A1 2710/4885TSHR 1683/4885HSD17B10 1257/4885 |
| US-20070161685-A1 | HETEROCYCLIC CETP INHIBITORS | CETP, CES1, NPC1 | ALDH1A1 2353/4885TSHR 2250/4885HSD17B10 255/4885 |
| US-20230200214-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | ALDH1A1 969/4885TSHR 3804/4885HSD17B10 3064/4885 |
| US-11787794-B2 | Aminothiazole compounds and methods using same | BRCA1, ALDH7A1, MGMT | ALDH1A1 116/4885TSHR 4231/4885HSD17B10 560/4885 |
| US-20090226382-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | ALDH1A1 457/4885TSHR 3749/4885HSD17B10 221/4885 |
| US-20070135631-A1 | HETEROCYCLIC CETP INHIBITORS | CETP, CES1, NPC1 | ALDH1A1 2353/4885TSHR 2250/4885HSD17B10 255/4885 |
| US-11860536-B2 | Three-dimensional crosslinker composition and method of manufacturing electronic devices using the same | BMI1, SETDB1, EED | ALDH1A1 149/4885TSHR 4526/4885HSD17B10 1163/4885 |
| US-20090104136-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | ALDH1A1 457/4885TSHR 3749/4885HSD17B10 221/4885 |
| US-20230234929-A1 | RAS INHIBITORS | KRAS, NRAS, HRAS | ALDH1A1 4437/4885TSHR 3332/4885HSD17B10 4458/4885 |
| US-20230233569-A1 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | KRAS, HRAS, MTOR | ALDH1A1 4528/4885TSHR 4120/4885HSD17B10 4436/4885 |
| US-20090191141-A1 | HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR USING SAME | TET1, TET2, TET3 | ALDH1A1 457/4885TSHR 3749/4885HSD17B10 221/4885 |
| US-20230135758-A1 | ELONGATION FACTOR 1-ALPHA INHIBITORS AND USES THEREOF | EEF1A1, EEF1B2, EEF1G | ALDH1A1 3486/4885TSHR 4402/4885HSD17B10 2980/4885 |
| US-11700765-B2 | Organic electroluminescent materials and devices | SOD1, L1CAM, MCM2 | ALDH1A1 445/4885TSHR 4446/4885HSD17B10 3071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.